Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

David J. Sas; Peter C. Harris; Dawn S. Milliner

doi:10.1007/s00240-019-01166-6

Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

David J. Sas, Peter C. Harris, Dawn S. Milliner

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”. The correct dosage is: 0.1 g/kg/day divided BID-QID for children, 3–6 g per day divided BID-QID for adults.

Original language	English (US)
Pages (from-to)	93
Number of pages	1
Journal	Urolithiasis
Volume	48
Issue number	1
DOIs	https://doi.org/10.1007/s00240-019-01166-6
State	Published - Feb 1 2020

ASJC Scopus subject areas

Urology

Access to Document

10.1007/s00240-019-01166-6

Fingerprint Dive into the research topics of 'Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)'. Together they form a unique fingerprint.

Cite this

@article{e2492e5d764a48a2b69d713130074e30,

title = "Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)",

abstract = "The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”. The correct dosage is: 0.1 g/kg/day divided BID-QID for children, 3–6 g per day divided BID-QID for adults.",

author = "Sas, {David J.} and Harris, {Peter C.} and Milliner, {Dawn S.}",

year = "2020",

month = feb,

day = "1",

doi = "10.1007/s00240-019-01166-6",

language = "English (US)",

volume = "48",

pages = "93",

journal = "Urolithiasis",

issn = "2194-7228",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

AU - Sas, David J.

AU - Harris, Peter C.

AU - Milliner, Dawn S.

PY - 2020/2/1

Y1 - 2020/2/1

N2 - The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”. The correct dosage is: 0.1 g/kg/day divided BID-QID for children, 3–6 g per day divided BID-QID for adults.

AB - The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”. The correct dosage is: 0.1 g/kg/day divided BID-QID for children, 3–6 g per day divided BID-QID for adults.

UR - http://www.scopus.com/inward/record.url?scp=85074053468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074053468&partnerID=8YFLogxK

U2 - 10.1007/s00240-019-01166-6

DO - 10.1007/s00240-019-01166-6

M3 - Comment/debate

C2 - 31606780

AN - SCOPUS:85074053468

VL - 48

SP - 93

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

IS - 1

ER -

Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this